TTY Biopharm Company Limited (TPEX: 4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.20
-0.30 (-0.41%)
Sep 10, 2024, 1:30 PM CST

TTY Biopharm Company Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
1,1241,1291,094831.89924.18900.08
Upgrade
Depreciation & Amortization
180.89193.1180.69162.79153.86148.56
Upgrade
Other Amortization
8.687.85.594.493.143.78
Upgrade
Loss (Gain) From Sale of Assets
1.741.933.280.740.320.58
Upgrade
Asset Writedown & Restructuring Costs
114.18116.180.734.154.5882.69
Upgrade
Loss (Gain) From Sale of Investments
35.7435.74-0.21-0.16-0.38
Upgrade
Loss (Gain) on Equity Investments
-145.17-131.34-116.38-135.18-162.8746.84
Upgrade
Provision & Write-off of Bad Debts
1.35-1.933.5613.58-0.1-5.5
Upgrade
Other Operating Activities
123.9995.07110.34110.24-15.66100.98
Upgrade
Change in Accounts Receivable
-133.58-116.16-95.4-114.32-36.42-83.2
Upgrade
Change in Inventory
-54.34-56.75-83.95155.12-251.8-96.33
Upgrade
Change in Accounts Payable
-125.8811.9596.01-23.07-26.359.27
Upgrade
Change in Unearned Revenue
-25.55-18.89-6.6423.48-0.398.26
Upgrade
Change in Other Net Operating Assets
-18.62-179.8943.55222.24-65.9894.22
Upgrade
Operating Cash Flow
1,0871,0851,2361,256526.351,210
Upgrade
Operating Cash Flow Growth
-10.81%-12.17%-1.64%138.69%-56.49%12.67%
Upgrade
Capital Expenditures
-90.71-78.35-91.52-60.32-168.11-69.86
Upgrade
Sale of Property, Plant & Equipment
2.287.019.390.030.010.02
Upgrade
Cash Acquisitions
-242.87-----24.89
Upgrade
Sale (Purchase) of Intangibles
-14.35-21.23-43.98-13.84-13.75-0.78
Upgrade
Investment in Securities
15.96168.5534.68-14.1308.82-207.96
Upgrade
Other Investing Activities
-20.23-78.62-41.7-80.5620.2630.46
Upgrade
Investing Cash Flow
-349.91-2.63-133.14-168.78147.24-273.15
Upgrade
Short-Term Debt Issued
-10,28010,8905,4005,4007,700
Upgrade
Long-Term Debt Issued
-400430-720-
Upgrade
Total Debt Issued
9,98010,68011,3205,4006,1207,700
Upgrade
Short-Term Debt Repaid
--10,200-11,231-5,404-5,246-7,400
Upgrade
Long-Term Debt Repaid
--434.17-421.55-16.54-663.65-3.6
Upgrade
Total Debt Repaid
-9,957-10,634-11,653-5,421-5,910-7,404
Upgrade
Net Debt Issued (Repaid)
23.1845.83-332.62-20.54210.35296.4
Upgrade
Common Dividends Paid
-870.28-845.41-745.95-994.6-994.6-1,119
Upgrade
Other Financing Activities
-16.74-16.75-24.83-28.99-22.36-26.75
Upgrade
Financing Cash Flow
-863.83-816.33-1,103-1,044-806.61-849.27
Upgrade
Foreign Exchange Rate Adjustments
67.78-2.66135.85-44.91-65.41-37.57
Upgrade
Net Cash Flow
-58.92263.7135.07-1.48-198.4349.86
Upgrade
Free Cash Flow
996.341,0071,1441,196358.251,140
Upgrade
Free Cash Flow Growth
-12.26%-12.00%-4.33%233.86%-68.57%14.03%
Upgrade
Free Cash Flow Margin
17.40%18.29%22.61%26.37%8.49%25.52%
Upgrade
Free Cash Flow Per Share
4.004.044.604.801.444.58
Upgrade
Cash Interest Paid
36.1334.9923.2218.6719.615
Upgrade
Cash Income Tax Paid
286.65283.71277.92220.22311.47236.57
Upgrade
Levered Free Cash Flow
566.86737.63806.96980.02107.23812.46
Upgrade
Unlevered Free Cash Flow
589.44759.62821.24991.87119.36821.71
Upgrade
Change in Net Working Capital
361.23199.47-2.99-185.84454.1427.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.